Dr. Johanna Bendell picks the upcoming ASCO presentations she anticipates to be the most interesting in gastrointestinal research.
Dr. Johanna Bendell
• 3504 Impact of aspirin as secondary prevention in an unselected cohort of 25,644 patients with colorectal cancer: A population-based study.
• 3503 Vitamin D status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance).
Dr. Johanna Bendell is the director, GI Oncology Research, and associate director, drug development unit, Sarah Cannon Research Institute, Nashville, Tenn.